Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Return on Equity (2016 - 2025)

Historic Return on Equity for AtriCure (ATRC) over the last 15 years, with Q3 2025 value amounting to 0.06%.

  • AtriCure's Return on Equity rose 200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.1% for FY2024, which is 300.0% down from last year.
  • Latest data reveals that AtriCure reported Return on Equity of 0.06% as of Q3 2025, which was up 200.0% from 0.08% recorded in Q2 2025.
  • In the past 5 years, AtriCure's Return on Equity ranged from a high of 0.12% in Q2 2022 and a low of 0.15% during Q2 2021
  • Its 5-year average for Return on Equity is 0.05%, with a median of 0.08% in 2024.
  • Data for AtriCure's Return on Equity shows a peak YoY increase of 2600bps (in 2022) and a maximum YoY decrease of -2300bps (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows AtriCure's Return on Equity stood at 0.1% in 2021, then plummeted by -199bps to 0.1% in 2022, then surged by 36bps to 0.07% in 2023, then tumbled by -47bps to 0.1% in 2024, then skyrocketed by 37bps to 0.06% in 2025.
  • Its Return on Equity was 0.06% in Q3 2025, compared to 0.08% in Q2 2025 and 0.08% in Q1 2025.